1Ongenae K,Van Geel N,Naeyaert JM.Evidence for an autoimmune pathogenesis of vitiligo[J].Pigment Cell Res,2003,16 (2):90-100.
2Steitz J,Wenzel J,Gaffal E,et al.Initiation and regulation of CD8+ T cells recognizing melanocytic antigens in the epidermis:implications for the pathophysiology of vitiligo[J].Eur J Cell Biol,2004,83 (11-12):797-803.
3Franczuk A,Szepietowski JC,Noworolska A.Serum concentrations of interleukin-2 soluble receptor (IL-2 sR) in patients with vitiligo:relationship with type and extent of the disease[J].Acta Dermatovenerol Croat,2004,12(2):71 -76.
4Grunwald MH,Ben-Amitai D,Amichai B.Macrolactam immunomodulators (tacrolimus and pimecrolimus):new horizons in the topical treatment of inflammatory skin diseases[J].J Dermatol,2004,31 (8):592-602.
5Smith DA,Tofte SJ,Hanifin JM.Repigmentation of vitiligo with topical tacrolimus[J].Dermatology,2002,205 (3):301-303.
6Grimes PE,Soriano T,Dytoc MT.Topical tacrolimus for repigmentation of vitiligo[J].J Am Acad Dermatol,2002,47 (5):789 -791.
7Lepe V,Moncada B,Castanedo-Cazares JP,et al.A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo[J].Arch Dermatol,2003,139 (5):581-585.
8Grimes PE,Morris R,Avaniss-Aghajani E,et al.Topical tacrolimus therapy for vitiligo:therapeutic responses and skin messenger RNA expression of proinflammatory cytokines[J].J Am Acad Dermatol,2004,51(1):52-61.
9Kanwar AJ,Dogra S,Parsad D.Topical tacrolimus for treatment of childhood vitiligo in Asians[J].Clin Exp Dermatol,2004,29 (6):589-592.
10Silverberg NB,Lin P,Travis L,et al.Tacrolimus ointment promotes repigmentation of vitiligo in children:a review of 57 cases[J].J Am Acad Dermatol,2004,51 (5):760 -766.
9Marzia C, Daniele T, Emiliano A, et al. The effects of tacrolimus ointment on regulatory T lyphocytes in A topic Dermatitis. J Clin Immunol 2006 ; 26(4) : 370 - 375.
10Koo J Y,Fleischer A B Jr,Abramovits W,et al.Tacrolimus ointment is safe and effective in the treatment of atopic dermatitis:results in 8000 patients[J].J Am Acad Dermatol,2005,53(suppl2):195-205.
